| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.002 |